COMPARE · Data as of August 21, 2026
COR vs MCK
Verdict: Side-by-side breakdown using the Bull Rankings model. COR scored 66.9, MCK scored 65.6 — COR leads.
Compare another set
COR
Cencora, Inc.
66.9
$318.04 · $60.7B
fundamentals as of
Score gap
1.3
COR leads
MCK
McKesson Corporation
65.6
$858.90 · $100.1B
fundamentals as of
At a glance · who leads each dimension, on the model's own rules
- CheapestMCK23.0x
- Fastest growthMCK+8.8%
- Highest qualityCOR68 / 100
- Largest discount to fair valueCOR-43%
Side by side · every name on one set of axes
Growth against the P/E multiple. Up and to the right is cheaper and faster — the quality-growth idea in one picture. Points beyond the axis are pinned to the edge and marked off-scale rather than allowed to compress everything else.
The model, pillar by pillar (0–100 each)
COR
stronger →← stronger
MCK
68
Qualityreturns · margins · balance sheet
55
68
Growthrevenue & earnings expansion
79
65
Valuevaluation vs sector peers
65
COR and MCK split the three pillars evenly.
Fundamentals, head-to-head
COR
MCK
$4.1bB
FCF
$6.4bB+
+5.1%C+
Rev
+8.8%B
4.47D
D/E
—
23.6xB+
P/E
23.0xB+
0.66A-
PEG
1.61C+
Winner per row is the stronger grade; where grades tie, the better figure breaks it. A true tie or a missing value shows no highlight.
Valuation · DCF cross-check
COR
MCK
43% below
Price vs fair valuelower is cheaper
15% below
~-6%/yr
Growth the price implies10-yr FCF · lower = less priced in
~4%/yr
+59%
1-yr DCF upside
+4%
+76%
5-yr DCF upside
+18%
+106%
10-yr DCF upside
+43%
The DCF is a cross-check on intrinsic value, separate from the quality-growth score above.
Model signals
COR
Why this score
- Raising its dividend
- Durable high returns
MCK
Why this score
- Buying back stock
- Raising its dividend
The companies
CORCencora, Inc.
Why now
Medical Distribution · market cap $60.7b. 16% off the 52-week high of $377.54. PEG 0.66 — paying under fair value for the growth rate. 13 sell-side analysts rate this a Buy with a mean 1-yr target of $369.31 (implying +16% upside).
Moat
ROE 86% — top-decile capital efficiency. Either pricing leverage, low capital intensity, or aggressive buybacks; the durability story depends on which. FCF converts 155% of net income — earnings translate cleanly into cash, a sign that working capital and capex are well-disciplined. $60.7b market cap gives the company enough scale to absorb fixed costs that subscale competitors can't, without yet being so large that growth has to come from acquisition.
Risk
D/E 4.47 is elevated — limits strategic flexibility and raises refinancing exposure if rates stay higher for longer. Net margin 0.8% is thin — operating leverage cuts both ways; input-cost inflation or pricing pressure hits the bottom line first.
MCKMcKesson Corporation
Why now
Medical Distribution · market cap $100.1b. 14% off the 52-week high of $999.00. 16 sell-side analysts rate this a Buy with a mean 1-yr target of $986.94 (implying +15% upside).
Moat
FCF converts 140% of net income — earnings translate cleanly into cash, a sign that working capital and capex are well-disciplined. $100.1b market cap gives the company enough scale to absorb fixed costs that subscale competitors can't, without yet being so large that growth has to come from acquisition.
Risk
Net margin 1.1% is thin — operating leverage cuts both ways; input-cost inflation or pricing pressure hits the bottom line first. ROE -108% is below the long-run sustainable threshold of ~10% — capital efficiency would need to improve for the equity base to compound at the market rate.
Verdict — model-derived comparison
COR leads MCK by 2.4 points (66.8 to 64.4), its sharpest advantage coming in PEG (grade A-). A contrarian could still prefer MCK, which trades about 15% below our DCF fair value — a margin of safety the score doesn't reward. Note they play different roles — COR screens as value, MCK screens as growth — so the model rewards different traits for each.
Our AI analyst is busy right now, so this verdict is drawn directly from the pillars, grades and DCF above.
Not investment advice. The Bull Rankings publishes a quantitative ranking model and accompanying analysis for general informational purposes only. Nothing on this page is a recommendation to buy, sell, or hold any security; nothing is personalized to your circumstances, risk tolerance, or tax situation. Investing carries the risk of loss — invest at your own risk and consider consulting a licensed financial professional before acting on anything you read here. See terms and methodology for full disclosures.
Where COR and MCK diverge
On the headline score the gap is 1.3 points in favor of COR. They get there differently, though — each leads on a different pillar, so the better pick depends on which you weight.
- QualityCOR 68.0 · MCK 55.0COR +13.0
- GrowthCOR 68.1 · MCK 79.0MCK +10.9
- ValueCOR 64.5 · MCK 64.9level
Pillars run 0–100 against sector peers, so a score is a statement about a company relative to its own industry rather than to the other name here. A wide Value gap usually means the market already prices the difference in quality or growth — which is the trade-off this comparison comes down to.